Hemostatic efficacy of oxidized regenerated cellulose in laparoscopic or robotic colorectal cancer surgery : a prospective single-center study

Background: Intraoperative bleeding remains a concern in minimally invasive colorectal cancer surgery. Oxidized regenerated cellulose (ORC) is widely used as an adjunctive topical hemostatic agent; however, evidence of its efficacy in laparoscopic or robotic colorectal surgery remains limited. This study aimed to evaluate the hemostatic efficacy and short-term safety of ORC gauze (Surgiguard ® ) in minimally invasive colorectal cancer surgery. Materials and Methods: This prospective single-center study included patients who underwent laparoscopic or robotic surgery for colorectal cancer between November 2022 and January 2024. Patients were divided into the Surgi group, in which ORC gauze was applied to control bleeding that was difficult to manage using conventional methods, and the non-Surgi group. Results: Of 50 patients included, 16 received Surgiguard ® and 34 did not. Baseline characteristics did not differ significantly between the groups. Successful hemostasis was achieved following Surgiguard ® application in 15 of 16 patients (93.8%). Although intraoperative blood loss was significantly greater in the Surgi group than in the non-Surgi group, postoperative transfusion rates and hemoglobin levels did not differ significantly. The Surgi group started drinking water and consuming a soft diet earlier and had a shorter postoperative hospital stay. Thirty-day morbidity did not differ significantly between the groups, and no 30-day mortality occurred. Conclusion: Surgiguard ® demonstrated adequate hemostatic performance during laparoscopic or robotic colorectal cancer surgery. Thirty-day morbidity did not differ significantly between the groups, supporting its potential role as an adjunctive hemostatic tool in minimally invasive colorectal surgery.

Authors

Institutions

Publication Details

Journal
Journal of Innovative Medical Technology
Published
2026-11-18
DOI
https://doi.org/10.61940/jimt.260015
Primary Topic
Hemostasis and retained surgical items
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hemostatic efficacy of oxidized regenerated cellulose in laparoscopic or robotic colorectal cancer surgery : a prospective single-center study

Woon Kyung Jeong, Seong Kyu Baek, Sung Uk Bae, Kyeong Eui Kim
1 links
Journal of Innovative Medical Technology
Hemostasis and retained surgical items
article

Hemostatic efficacy of oxidized regenerated cellulose in laparoscopic or robotic colorectal cancer surgery : a prospective single-center study

Woon Kyung Jeong, Seong Kyu Baek, Sung Uk Bae, Kyeong Eui Kim
article en

Abstract

Background: Intraoperative bleeding remains a concern in minimally invasive colorectal cancer surgery. Oxidized regenerated cellulose (ORC) is widely used as an adjunctive topical hemostatic agent; however, evidence of its efficacy in laparoscopic or robotic colorectal surgery remains limited. This study aimed to evaluate the hemostatic efficacy and short-term safety of ORC gauze (Surgiguard ® ) in minimally invasive colorectal cancer surgery. Materials and Methods: This prospective single-center study included patients who underwent laparoscopic or robotic surgery for colorectal cancer between November 2022 and January 2024. Patients were divided into the Surgi group, in which ORC gauze was applied to control bleeding that was difficult to manage using conventional methods, and the non-Surgi group. Results: Of 50 patients included, 16 received Surgiguard ® and 34 did not. Baseline characteristics did not differ significantly between the groups. Successful hemostasis was achieved following Surgiguard ® application in 15 of 16 patients (93.8%). Although intraoperative blood loss was significantly greater in the Surgi group than in the non-Surgi group, postoperative transfusion rates and hemoglobin levels did not differ significantly. The Surgi group started drinking water and consuming a soft diet earlier and had a shorter postoperative hospital stay. Thirty-day morbidity did not differ significantly between the groups, and no 30-day mortality occurred. Conclusion: Surgiguard ® demonstrated adequate hemostatic performance during laparoscopic or robotic colorectal cancer surgery. Thirty-day morbidity did not differ significantly between the groups, supporting its potential role as an adjunctive hemostatic tool in minimally invasive colorectal surgery.

Journal of Innovative Medical TechnologyVol. 4(2)
Inje University (KR), Inje University Busan Paik Hospital (KR), Keimyung University Dongsan Hospital (KR), Keimyung University (KR)
Good health and well-being
Hemostasis and retained surgical items
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon